Provided by Tiger Fintech (Singapore) Pte. Ltd.

Neuronetics Inc.

4.49
+0.04000.90%
Post-market: 4.490.00000.00%17:57 EDT
Volume:442.66K
Turnover:1.97M
Market Cap:296.85M
PE:-3.68
High:4.53
Open:4.43
Low:4.38
Close:4.45
Loading ...

Neuronetics' (NASDAQ:STIM) growing losses don't faze investors as the stock hikes 13% this past week

Simply Wall St.
·
23 Jul

Neuronetics Inc. Files Initial Statement of Beneficial Ownership for EVP, CFO and Treasurer Steven Pfanstiel

Reuters
·
16 Jul

BRIEF-Neuronetics Appoints New Chief Financial Officer

Reuters
·
15 Jul

Neuronetics Inc. Appoints Steven Pfanstiel as New Chief Financial Officer Amid Strategic Growth Plans

Reuters
·
15 Jul

BRIEF-Neuronetics Files For Mixed Shelf Of Up To $250 Million

Reuters
·
04 Jul

Neuronetics announces presence at CTMSS meeting, progress in Greenbrook program

TIPRANKS
·
10 Jun

Neuronetics Inc. Announces New Clinical Study on TMS Efficacy in Elderly Patients at 2025 CTMSS Annual Meeting

Reuters
·
10 Jun

Neuronetics set to join Russell 2000, Russell 3000 Indexes

TIPRANKS
·
03 Jun

Neuronetics Inc. Conducted Annual Stockholders Meeting

Reuters
·
28 May

Neuronetics Inc. EVP, CFO and Treasurer Stephen Furlong Reports Disposal of Common Shares

Reuters
·
15 May

Neuronetics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
06 May

Neuronetics Q1 EPS $(0.21) Misses $(0.14) Estimate, Sales $31.98M Beat $29.07M Estimate

Benzinga
·
06 May

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
06 May

Neuronetics Inc expected to post a loss of 12 cents a share - Earnings Preview

Reuters
·
02 May

Why Neuronetics, Inc. (STIM) is Surging in 2025

Insider Monkey
·
30 Apr

Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call

GlobeNewswire
·
22 Apr

Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression

GlobeNewswire
·
31 Mar

Neuronetics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
30 Mar

William Blair Keeps Their Hold Rating on Neuronetics (STIM)

TIPRANKS
·
28 Mar

BRIEF-Neuronetics Some Non-Cash Revisions Made To Financial Statements Related To Co's Acquisition Of Greenbrook Tms & Shares Outstanding In Q4

Reuters
·
28 Mar